SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001564590-19-037396
Filing Date
2019-10-22
Accepted
2019-10-22 16:18:15
Documents
6
Period of Report
2019-11-06
Effectiveness Date
2019-10-22

Document Format Files

Seq Description Document Type Size
1 DEF 14A tcon-def14a_20191106.htm DEF 14A 211105
2 GRAPHIC gzas2lnf0vs3000005.jpg GRAPHIC 61786
3 GRAPHIC gzas2lnf0vs3000001.jpg GRAPHIC 3781
4 GRAPHIC gzas2lnf0vs3000002.jpg GRAPHIC 1899
5 GRAPHIC gzas2lnf0vs3000004.jpg GRAPHIC 64610
6 GRAPHIC gzas2lnf0vs3000003.jpg GRAPHIC 1899
  Complete submission text file 0001564590-19-037396.txt   397554
Mailing Address 4350 LA JOLLA VILLAGE DRIVE SUITE 800 San Diego CA 92122
Business Address 4350 LA JOLLA VILLAGE DRIVE SUITE 800 San Diego CA 92122 858-550-0780
Tracon Pharmaceuticals, Inc. (Filer) CIK: 0001394319 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36818 | Film No.: 191161902
SIC: 2836 Biological Products, (No Diagnostic Substances)